[Bacteremia due to Providencia rettgeri].
Goenaga
M A
MA
María Morán
J
J
Carrera
J A
JA
Garde
C
C
Millet
M
M
D000328:Adult; D016470:Bacteremia / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D002939:Ciprofloxacin / Q000627:therapeutic use; D004198:Disease Susceptibility; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications; D015242:Ofloxacin / Q000627:therapeutic use; D011532:Providencia / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity*; D014549:Urinary Incontinence / Q000209:etiology; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000209:etiology
D005839:Gentamicins; D002939:Ciprofloxacin; D015242:Ofloxacin